Not checked for notices yet.

Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases

Wei-Yu Chen, Tzu-Hsien Tsai, Jenq-Lin Yang and 1 more

Cellular Physiology and Biochemistry · 2018

doi:10.1159/000492885

Cited by papers we hold 2

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction · 2023
No notice
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives · 2019
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.